DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02269 WUXI BIO

Closed Add to Porfolio
Index Constituent : Hang Seng Index, HS Composite Index, HS Comp.LargeCap Ind, HS Comp. L & M Index, HS HK 35, Stock Connect HK Ind
Major Shareholders Li Ge & Associates (12.53%) Sector Health Care & Biotechnology
Web Site http://www.wuxibiologics.com Tel N/A
Email Info@wuxibiologics.com Fax N/A
Related Equities N/A
Principal Activities The Group is principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in biologics industry.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
劉曉鐘 724,935,597(L)  59.20(L)  22/06/2018
張朝暉 724,935,597(L)  59.20(L)  22/06/2018
李革 724,935,597(L)  59.20(L)  22/06/2018
趙寧 724,935,597(L)  59.20(L)  22/06/2018
New WuXi Life Science Holdings Limited 676,380,917(L)  55.24(L)  22/06/2018
JPMorgan Chase & Co. 61,952,334(L) 3,730,884(S) 38,416,948(P)  5.05(L) 0.30(S) 3.13(P)  14/01/2019
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
周偉昌 5,931,000(L)  0.51(L)  12/01/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top